CRP and coronary artery disorder: Elevated levels of inflammatory biomarkers including c-reactive protein (CRP), soluble intercellular adhesion molecule 1 (sICAM1), soluble vascular cell adhesion molecule-1, and tumor necrosis factor-α (TNF-α) are associated with an increased risk of cardiovascular events in patients with known CHD including survivors of a recent ACS [67–70].